Find and Pitch Jounalists, Get Your Story Covered

Tags: anemia myelofibrosis splenomegaly bacterial infection janus

	Profile	Recent Articles on Subject
1	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation - 3 months ago Mezigdomide Combinations Show Promise in Multiple Myeloma - 3 months ago Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 9 months ago Daratumumab Added to Standard Therapy Improves PFS in Multiple Myeloma - over 1 year ago Why Some Myeloma Patients Refuse Stem Cell Transplant - over 1 year ago
2	Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA Healthcareoncologypharmacyeducation	Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies - 3 months ago Final Thoughts - 5 months ago Personalizing Treatments and Patient Education - 5 months ago Evaluating New Data for Transplant-Eligible Patients With NDMM: PERSEUS, IsKia, and GMMG HD7 - 6 months ago Real-World Considerations for New Therapies - 6 months ago Impact of Transplant Eligibility on Treatment Selection - 6 months ago
3	<em>The Scientist</em> The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	What Drives Myeloid Cell Responses to Disease - 4 months ago
4	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	ASH 2024 Recap: Movement in Multiple Myeloma, Cell Therapy, Sickle Cell Disease & More - 4 months ago FDA Rejection Delays Regeneron From Competing With J&J, Pfizer in Multiple Myeloma - 8 months ago
5	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	FDA Investigating Blood Cancer Risk With Gene Therapy Skysona - 4 months ago Epstein-Barr and MS; When Lewy Pathology Starts; Alzheimer's Blood Test Assessed - about 1 year ago
6	Ryan Haumschild, PharmD, MS, MBA Pharmacy Times Director of Pharmacy. Editorial Board member. Atlanta, Georgia pharmacyhealthcareeditorial workadvisory	Current Landscape of Bispecific Therapies for RRMM - 4 months ago
7	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Arcellx to present positive data on multiple myeloma treatments - 5 months ago
8	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Early data from Arcellx, Gilead suggest CAR-T for multiple myeloma could offer safety benefit - 5 months ago
9	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - 6 months ago Relapsed/Refractory Multiple Myeloma Treatment Advances With Three BiTE Therapy Options - about 1 year ago Subcutaneous Daratumumab Plus VRd Significantly Improved PFS, Increased Depth of Response in Patients With Newly Diagnosed Multiple Myeloma - over 1 year ago
10	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma - 6 months ago Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers - 7 months ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - about 1 year ago How a Multi-Cancer Screening Test Would Play Out in the Clinic - over 1 year ago

Journalists covering Multiple myeloma,plasma cell cancer,bone marrow cancer,M protein,CRAB symptoms,monoclonal gammopathy,stem cell transplant,immunomodulatory drugs,proteasome inhibitors,skeletal survey,serum free light chain assay,bone lesions,hypercalcemia,renal insufficiency,anemia